Quarterly Activities & Cashflow Report

Biome Australia Ltd has reported strong financial performance in the June 2024 quarter, with record cash receipts of $3.23m, a 118% increase compared to the previous corresponding period. Quarterly sales revenue reached $3.8m, showing an 88% increase year-on-year. The company maintained a gross margin above 60% and closed the fiscal year with a cash balance of $2.86m. Biome achieved positive cash flow and EBITDA for the third and second consecutive quarters, respectively, in FY24.

Same-store pharmacy sales increased by 78%, reflecting the company's success in commercialization and business development. Biome plans to invest in continued growth through business development opportunities, research, strategic partnerships, and new markets. The company aims to leverage its brand trust and customer engagement to drive future growth.

Investors are encouraged to visit the newly launched interactive investor hub for more information and to sign up for company updates. For any questions or further details regarding the financial results and strategic plans, please reach out to our investor relations team at corporate@biomeaustralia.com or call (03) 9017 5800. Biome looks forward to another year of significant growth and continued success in the microbiome health sector.